Overview

Compare the Pharmacokinetics of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe

Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the pharmacokinetics of NVP-1205 and coadministration of rosuvastatin and ezetimibe.
Phase:
Phase 1
Details
Lead Sponsor:
Navipharm Corporation
Treatments:
Ezetimibe
Rosuvastatin Calcium